GIM
VIVE

Granahan Investment Management’s VIVEVE MED INC VIVE Stock Holding History

Granahan Investment Management’s Portfolio VIVE Stock Details VIVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-595
Closed -$559K – 190
2019
Q1 		$559K Sell
595
-29
-5% -$30.8K 0.03% 184
2018
Q4 		$655K Sell
624
-12
-2% -$28.8K 0.05% 173
2018
Q3 		$1.7M Sell
636
-157
-20% -$445K 0.09% 164
2018
Q2 		$2.16M Buy
793
+429
+118% +$1.24M 0.13% 160
2018
Q1 		$1.33M Buy
364
+247
+211% +$1.07M 0.1% 162
2017
Q4 		$583K Buy
117
+15
+15% +$78.1K 0.05% 185
2017
Q3 		$535K Buy
102
+25
+32% +$154K 0.04% 168
2017
Q2 		$553K Sell
77
-319
-81% -$2.38M 0.05% 164
2017
Q1 		$2.51M Buy
396
+29
+8% +$141K 0.25% 118
2016
Q4 		$1.89M Buy
367
+76
+26% +$452K 0.07% 170
2016
Q3 		$2.1M Buy
291
+12
+4% +$79.7K 0.07% 179
2016
Q2 		$1.15M Buy
+279
New +$1.3M 0.04% 202

Other funds holding VIVE

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Granahan Investment Management's VIVE Position: Q2 2019 in Review

Granahan Investment Management sold out of VIVEVE MED INC (VIVE) in Q2 2019, closing a stake of 595 shares — an estimated $559K sold.

Granahan Investment Management first reported a position in VIVE in Q2 2016 and held it in 12 quarters. The position peaked at $2.51M in Q1 2017. 30 funds tracked by Wall St. Rank hold VIVE as of Q2 2019.

  • Granahan Investment Management reported no remaining VIVEVE MED INC position as of Q2 2019 after selling out during the quarter.
  • Granahan Investment Management sold 595 VIVEVE MED INC shares in Q2 2019, an estimated $559K.
  • Granahan Investment Management first reported a position in VIVEVE MED INC in Q2 2016 and held it in 12 quarters.
  • Granahan Investment Management's VIVEVE MED INC position peaked at $2.51M in Q1 2017.
  • 30 funds tracked by Wall St. Rank held VIVEVE MED INC as of Q2 2019.

Based on Granahan Investment Management's 13F filing for Q2 2019, filed 14 Aug 2019.